Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey, M Birrer… - International Journal of …, 2011 - ijgc.bmj.com
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey… - International …, 2011 - research.manchester.ac.uk
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer

JA Ledermann, C Marth, MS Carey… - International …, 2011 - search.proquest.com
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

[PDF][PDF] Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer

M Birrer, DDL Bowtell, S Kaye, A Okamoto… - Int J Gynecol …, 2011 - academia.edu
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

[引用][C] Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey… - International …, 2011 - produccioncientifica.ucm.es

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

J Ledermann, C Marth, M Carey, M Birrer… - INTERNATIONAL …, 2011 - publicatt.unicatt.it
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey… - … : official journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

[引用][C] Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey, M Birrer… - 2011 - repository.ubn.ru.nl
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

JA Ledermann, C Marth, MS Carey, M Birrer… - … : Official Journal of the …, 2011 - europepmc.org
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer

JA Ledermann, C Marth, MS Carey… - International Journal …, 2011 - eprints.gla.ac.uk
There is now a greater understanding of the molecular pathways in ovarian cancer, and
using this knowledge, a large number of new therapeutic agents can be tested. The success …